Clinical Trial Update: Phase II Trial of Doxorubicin and Bortezomib in Patients With Incurable Adenoid Cystic Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

Phase II trial evaluating doxorubicin and bortezomib in patients with incurable adenoid cystic carcinoma of the head and neck has completed. Results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma

Drugs mentioned

• Bortezomib (bortezomib)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: University of Pittsburgh | Conditions: Adenoid Cystic Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-11-07